Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tyrosine kinases as targets for cancer therapy.

× No keyword cloud information.

394 in total

1. Tyrosine residues at the carboxyl terminus of Vav1 play an important role in regulation of its biological activity.

Authors: Galit Lazer; Liron Pe'er; Marganit Farago; Kazuya Machida; Bruce J Mayer; Shulamit Katzav
Journal: J Biol Chem Date: 2010-05-10 Impact factor: 5.157

2. Frequency and management of troponin I elevation in patients treated with molecular targeted therapies in phase I trials.

Authors: Stephane Ederhy; Christophe Massard; Ghislaine Dufaitre; Ratio Balheda; Catherine Meuleman; Carlos Gomez Rocca; Hassane Izzedine; Ariel Cohen; Jean-Charles Soria
Journal: Invest New Drugs Date: 2010-10-06 Impact factor: 3.850

3. An overview of the c-MET signaling pathway.

Authors: Shawna Leslie Organ; Ming-Sound Tsao
Journal: Ther Adv Med Oncol Date: 2011-11 Impact factor: 8.168

4. A computational workflow for the design of irreversible inhibitors of protein kinases.

Authors: Alberto Del Rio; Miriam Sgobba; Marco Daniele Parenti; Gianluca Degliesposti; Rosetta Forestiero; Claudia Percivalle; Pier Franco Conte; Mauro Freccero; Giulio Rastelli
Journal: J Comput Aided Mol Des Date: 2010-03-21 Impact factor: 3.686

Review 5. Tyrosine kinases in inflammatory dermatologic disease.

Authors: Ricardo T Paniagua; David F Fiorentino; Lorinda Chung; William H Robinson
Journal: J Am Acad Dermatol Date: 2010-06-26 Impact factor: 11.527

6. The concomitant use of tyrosine kinase inhibitors and proton pump inhibitors: Prevalence, predictors, and impact on survival and discontinuation of therapy in older adults with cancer.

Authors: Manvi Sharma; Holly M Holmes; Hemalkumar B Mehta; Hua Chen; Rajender R Aparasu; Ya-Chen T Shih; Sharon H Giordano; Michael L Johnson
Journal: Cancer Date: 2019-01-03 Impact factor: 6.860

7. Mutation profile of JAK2 transcripts in patients with chronic myeloproliferative neoplasias.

Authors: Wanlong Ma; Hagop Kantarjian; Xi Zhang; Chen-Hsiung Yeh; Zhong J Zhang; Srdan Verstovsek; Maher Albitar
Journal: J Mol Diagn Date: 2008-12-12 Impact factor: 5.568

8. Bruton's tyrosine kinase is a potential therapeutic target in prostate cancer.

Authors: Leila Kokabee; Xianhui Wang; Christopher J Sevinsky; Wei Lin Winnie Wang; Lindsay Cheu; Sridar V Chittur; Morteza Karimipoor; Martin Tenniswood; Douglas S Conklin
Journal: Cancer Biol Ther Date: 2015-09-18 Impact factor: 4.742

9. Orolabial signs are important clues for diagnosis of the rare endocrine syndrome MEN 2B. Presentation of two unrelated cases.

Authors: Agnes Sallai; Eva Hosszú; Péter Gergics; Károly Rácz; György Fekete
Journal: Eur J Pediatr Date: 2007-06-19 Impact factor: 3.183

Review 10. Update on Keloid Management: Clinical and Basic Science Advances.

Authors: Martha H Viera; Alejandra C Vivas; Brian Berman
Journal: Adv Wound Care (New Rochelle) Date: 2012-10 Impact factor: 4.730